Cargando…
The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review
In 2018, the first list of rare diseases was published by the National Health Council of China, and multiple sclerosis (MS) was included in this list. Since then, the Chinese government and neurologists have made efforts to improve the clinical outcomes of patients with MS. During last few years, th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349092/ https://www.ncbi.nlm.nih.gov/pubmed/35583839 http://dx.doi.org/10.1007/s10072-022-06126-4 |